the end-stage liver disease with incomplete intestinal obstruction
Conditions
Interventions
Control group:Basic treatment
Experimental group:Basic treatment plus terlipression
Sponsors
The Second Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.The patients with end-stage liver disease in the Second Affiliated Hospital of Chongqing Medical University included decompensated liver cirrhosis, chronic liver failure and acute on chronic liver failure. 2.Aged 18 to 75 years; 3.The patients with abdominal distension, constipation or no constipation, stop exhaust of hepatic hilum and incomplete intestinal obstruction indicated by abdominal imaging; 4.Sign informed consent.
Exclusion criteria
Exclusion criteria: 1.Severe cardiopulmonary insufficiency; 2.Patients with hypertension 3.Patients with advanced liver cancer and peritoneal tumor; 4.Abdominal surgery within 3 months; 5.The patients were allergic to terlipressin; 6.Those who are not willing to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement rate of intestinal obstruction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement time of intestinal obstruction;Incidence of adverse events; | — |
Countries
China
Contacts
Public ContactZhou Zhi
The Second Affiliated Hospital of Chongqing Medical University
Outcome results
None listed